At a glance
ClinicalIndex Comparison RecordN/ACompleted· 600 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LCCC 1608 - HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
In Brief
An observational study for Esophageal Squamous Cell Carcinoma. Completed, enrolled 600 participants across 2 sites.
Detailed Summary
The primary purpose of this single-center, case-control, non-interventional study is to determine risk factors which contribute to the development of esophageal squamous cell carcinoma (ESCC) at Kamuzu Central Hospital (KCH) and St. Gabriel Hospital (SGH) in Malawi.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Squamous Cell Carcinoma
CountriesMalawi
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartJul 2017
Primary CompletionDec 2022
TodayJul 2026
First PostedMay 19, 2017
Enrollment StartJul 26, 2017
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 9.1 years ago